D. V. Ablashi

1.9k total citations
62 papers, 1.5k citations indexed

About

D. V. Ablashi is a scholar working on Epidemiology, Oncology and Infectious Diseases. According to data from OpenAlex, D. V. Ablashi has authored 62 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Epidemiology, 38 papers in Oncology and 14 papers in Infectious Diseases. Recurrent topics in D. V. Ablashi's work include Cytomegalovirus and herpesvirus research (45 papers), Viral-associated cancers and disorders (37 papers) and Herpesvirus Infections and Treatments (24 papers). D. V. Ablashi is often cited by papers focused on Cytomegalovirus and herpesvirus research (45 papers), Viral-associated cancers and disorders (37 papers) and Herpesvirus Infections and Treatments (24 papers). D. V. Ablashi collaborates with scholars based in United States, Germany and Canada. D. V. Ablashi's co-authors include S. Zaki Salahuddin, Rosella Gallo, J Menezes, Louis Flamand, G. R. F. Krueger, John Hiscott, Jean Gosselin, Mario D’Addario, Ioan Ștefănescu and P D Markham and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

D. V. Ablashi

59 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. V. Ablashi United States 18 1.2k 795 421 196 96 62 1.5k
Jodi B. Black United States 20 1.2k 1.0× 848 1.1× 520 1.2× 124 0.6× 36 0.4× 36 1.5k
A. Gautheret-Dejean France 21 1.2k 1.1× 698 0.9× 464 1.1× 70 0.4× 103 1.1× 73 1.5k
Lawrence A. Falk United States 21 760 0.7× 684 0.9× 206 0.5× 240 1.2× 150 1.6× 39 1.1k
Bernhard Kramarsky United States 10 1.2k 1.1× 760 1.0× 473 1.1× 117 0.6× 59 0.6× 14 1.5k
J. H. Joncas Canada 22 621 0.5× 611 0.8× 458 1.1× 193 1.0× 27 0.3× 62 1.3k
Gregory E. Halligan United States 8 1.0k 0.9× 636 0.8× 380 0.9× 49 0.3× 42 0.4× 18 1.3k
Junji Sashihara Japan 14 761 0.7× 654 0.8× 191 0.5× 258 1.3× 29 0.3× 16 1.1k
Jean‐Thierry Aubin France 20 877 0.8× 440 0.6× 483 1.1× 91 0.5× 55 0.6× 43 1.2k
Toshio Kondo Japan 11 2.1k 1.8× 1.2k 1.5× 835 2.0× 89 0.5× 55 0.6× 13 2.2k
Tania Crough Australia 15 1.2k 1.0× 374 0.5× 190 0.5× 638 3.3× 74 0.8× 19 1.5k

Countries citing papers authored by D. V. Ablashi

Since Specialization
Citations

This map shows the geographic impact of D. V. Ablashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. V. Ablashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. V. Ablashi more than expected).

Fields of papers citing papers by D. V. Ablashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. V. Ablashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. V. Ablashi. The network helps show where D. V. Ablashi may publish in the future.

Co-authorship network of co-authors of D. V. Ablashi

This figure shows the co-authorship network connecting the top 25 collaborators of D. V. Ablashi. A scholar is included among the top collaborators of D. V. Ablashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. V. Ablashi. D. V. Ablashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Müller, Andreas, Caspar Franzen, Μ. Wagner, et al.. (2000). Human Herpesvirus Type 8 in HIV-infected Patients with Interstitial Pneumonitis. Journal of Infection. 40(3). 242–247. 15 indexed citations
2.
Engels, Eric A., et al.. (1999). Risk of Transfusion-Associated Transmission of Human Herpesvirus 8. JNCI Journal of the National Cancer Institute. 91(20). 1773–1775. 43 indexed citations
3.
Ablashi, D. V., John G. Bernbaum, Louise G. Chatlynne, et al.. (1998). Propagation and characterization of human herpesvirus-7 (HHV-7) isolates in a continuous T-lymphoblastoid cell line (SupT1). Journal of Virological Methods. 73(2). 123–140. 13 indexed citations
4.
Ablashi, D. V., et al.. (1995). Human herpesvirus-7 (HHV-7): current status. Clinical and Diagnostic Virology. 4(1). 1–13. 45 indexed citations
5.
Krueger, G. R. F., et al.. (1995). Clinical correlates of infection with human herpesvirus-6.. PubMed. 8(4). 457–85. 43 indexed citations
6.
Qavi, Hamida, et al.. (1995). HIV-1 and HHV-6 antigens and transcripts in retinas of patients with AIDS in the absence of human cytomegalovirus.. PubMed. 36(10). 2040–7. 20 indexed citations
7.
Ablashi, D. V., et al.. (1995). Human herpesvirus-7 (HHV-7).. PubMed. 8(4). 549–54. 12 indexed citations
8.
Qavi, Hamida, et al.. (1995). Possible role of HHV-6 in the development of AIDS retinitis.. PubMed. 8(4). 527–32. 9 indexed citations
9.
Ablashi, D. V., Z. N. Berneman, Malik Williams, et al.. (1995). Ampligen inhibits human herpesvirus-6 in vitro.. PubMed. 8(4). 587–91. 11 indexed citations
10.
Yadav, M, Anil Chandrashekran, DM Vasudevan, & D. V. Ablashi. (1994). Frequent Detection of Human Herpesvirus 6 in Oral Carcinoma. JNCI Journal of the National Cancer Institute. 86(23). 1792–1794. 28 indexed citations
11.
Cirone, Mara, Claudia Zompetta, Antonio Angeloni, et al.. (1992). Infection by Human Herpesvirus 6 (HHV-6) of Human Lymphoid T Cells Occurs Through an Endocytic Pathway. AIDS Research and Human Retroviruses. 8(12). 2031–2037. 19 indexed citations
12.
Lusso, Paolo, P D Markham, Erwin Tschachler, et al.. (1988). In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6).. The Journal of Experimental Medicine. 167(5). 1659–1670. 254 indexed citations
13.
Buchbinder, Aby, Steven F. Josephs, D. V. Ablashi, et al.. (1988). Polymerase chain reaction amplification and in situ hybridization for the detection of human B-lymphotropic virus. Journal of Virological Methods. 21(1-4). 191–197. 55 indexed citations
14.
Streicher, Howard, Chia‐Yen Hung, D. V. Ablashi, et al.. (1988). In vitro inhibition of human herpesvirus-6 by phosphonoformate. Journal of Virological Methods. 21(1-4). 301–304. 32 indexed citations
15.
Krueger, G. R. F., Birgit Koch, Albert Ramon, et al.. (1988). Antibody prevalence to HBLV (human herpesvirus-6, HHV-6) and suggestive pathogenicity in the general population and in patients with immune deficiency syndromes. Journal of Virological Methods. 21(1-4). 125–131. 39 indexed citations
16.
Ablashi, D. V., John E. Dahlberg, Grace B. Cannon, et al.. (1988). Detection of antibodies to Herpesvirus saimiri late antigens in human sera.. PubMed. 29(4). 217–26. 4 indexed citations
17.
18.
Ablashi, D. V., et al.. (1980). Herpesvirus saimiri-induced malignant lymphoma in inbred strain III/J rabbits (Oryctolagus cuniculus). Journal of Cancer Research and Clinical Oncology. 98(2). 165–172. 4 indexed citations
19.
Ablashi, D. V., et al.. (1979). Extraction of Soluble Antigens of Epstein-Barr Virus, <italic>Herpervirus saimiri</italic>, and <italic> Herpesvirus ateles </italic> With the Use of Glycine. JNCI Journal of the National Cancer Institute. 62(5). 1173–5. 7 indexed citations
20.
Neubauer, R H, William C. Wallen, Harvey Rabin, G. R. Pearson, & D. V. Ablashi. (1974). Virological Investigations of Herpesvirus saimiri-lnSectedOwl Monkeys. Journal of Medical Primatology. 3(1). 27–40. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jodi B. Black Breakdown of academic impact, for papers by A. Gautheret-Dejean Breakdown of academic impact, for papers by Lawrence A. Falk Breakdown of academic impact, for papers by Bernhard Kramarsky Breakdown of academic impact, for papers by J. H. Joncas Breakdown of academic impact, for papers by Gregory E. Halligan Breakdown of academic impact, for papers by Junji Sashihara Breakdown of academic impact, for papers by Jean‐Thierry Aubin Breakdown of academic impact, for papers by Toshio Kondo Breakdown of academic impact, for papers by Tania Crough
Rankless by CCL
2026